LOGC

LogicBio Therapeutics, Inc. Common Stock

Delisted

LOGC was delisted on the 15th of November, 2022.

57 hedge funds and large institutions have $37M invested in LogicBio Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 11 closing their positions.

Holders
57
Holders Change
Holders Change %
0%
% of All Funds
0.88%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
12
Reduced
10
Closed
11
Calls
$5K
Puts
$32K
Net Calls
-$27K
Net Calls Change
+$16K
Name Holding Trade Value Shares
Change
Shares
Change %
CFA
51
Carroll Financial Associates
North Carolina
$1K
JPMorgan Chase & Co
52
JPMorgan Chase & Co
New York
$1K +$1K +344 New
LPC
53
Lion Point Capital
New York
-$2.29M -500,000 Closed
E
54
Ergoteles
New York
-$301K -65,827 Closed
Renaissance Technologies
55
Renaissance Technologies
New York
-$216K -47,200 Closed
HF
56
HRT Financial
New York
-$192K -42,074 Closed
Marshall Wace
57
Marshall Wace
United Kingdom
-$181K -39,523 Closed
SFM
58
Sphera Funds Management
Israel
-$110K -24,042 Closed
IWM
59
IHT Wealth Management
Illinois
-$61K -13,225 Closed
JMF
60
Johnson Midwest Financial
Iowa
-$3K -715 Closed
TWA
61
TCI Wealth Advisors
Arizona
-$2K -344 Closed
RE
62
RBC Europe
United Kingdom
-$1.26K -275 Closed
TFA
63
Toth Financial Advisory
Virginia
-$1K -150 Closed